A group of advisers to the Food and Drug Administration agreed Wednesday that COVID-19 vaccines will likely need to be updated to keep pace with a fast-changing coronavirus, but said they would need more information to guide future decisions.
The FDA convened the group, made up of independent vaccine and public health experts, to provide input on how drugmakers should adapt their vaccines to better guard against variants like omicron, or others that might emerge over time.
